{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T11:22:14Z","timestamp":1785151334643,"version":"3.55.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,12,6]],"date-time":"2018-12-06T00:00:00Z","timestamp":1544054400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1245\/s10434-018-7007-3","type":"journal-article","created":{"date-parts":[[2018,12,6]],"date-time":"2018-12-06T19:36:17Z","timestamp":1544124977000},"page":"473-481","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Outcomes in Peritoneal Dissemination from Signet Ring Cell Carcinoma of the Appendix Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy"],"prefix":"10.1245","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6125-3170","authenticated-orcid":false,"given":"Carlos","family":"Munoz-Zuluaga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4132-9489","authenticated-orcid":false,"given":"Armando","family":"Sardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Caitlin","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol","family":"Nieroda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2641-1564","authenticated-orcid":false,"given":"Michelle","family":"Sittig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"MacDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vadim","family":"Gushchin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,12,6]]},"reference":[{"issue":"12","key":"7007_CR1","doi-asserted-by":"publisher","first-page":"3307","DOI":"10.1002\/cncr.10589","volume":"94","author":"ME McCusker","year":"2002","unstructured":"McCusker ME, Cote TR, Clegg LX, Sobin LH. Primary malignant neoplasms of the appendix: a population-based study from the surveillance, epidemiology and end-results program, 1973\u20131998. Cancer. 2002;94(12):3307\u201312.","journal-title":"Cancer"},{"issue":"2","key":"7007_CR2","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.ejso.2007.04.002","volume":"34","author":"RM Smeenk","year":"2008","unstructured":"Smeenk RM, van Velthuysen ML, Verwaal VJ, Zoetmulder FA. Appendiceal neoplasms and pseudomyxoma peritonei: a population based study. Eur J Surg Oncol. 2008;34(2):196\u2013201.","journal-title":"Eur J Surg Oncol"},{"key":"7007_CR3","unstructured":"Amin MB, Edge S, Greene F, et al. (eds.) AJCC Cancer Staging Manual. 8th ed, American Joint Commission on Cancer: Springer International Publishing; 2017."},{"issue":"13","key":"7007_CR4","doi-asserted-by":"publisher","first-page":"4218","DOI":"10.1245\/s10434-014-3869-1","volume":"21","author":"W Jimenez","year":"2014","unstructured":"Jimenez W, Sardi A, Nieroda C, et al. Predictive and prognostic survival factors in peritoneal carcinomatosis from appendiceal cancer after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2014;21(13):4218\u201325.","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"7007_CR5","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1245\/s10434-017-6310-8","volume":"25","author":"M Reghunathan","year":"2018","unstructured":"Reghunathan M, Kelly KJ, Valasek MA, Lowy AM, Baumgartner JM. Histologic predictors of recurrence in mucinous appendiceal tumors with peritoneal dissemination after HIPEC. Ann Surg Oncol. 2018;25(3):702\u20138.","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"7007_CR6","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1245\/s10434-015-4995-0","volume":"23","author":"C Ihemelandu","year":"2016","unstructured":"Ihemelandu C, Sugarbaker PH. Clinicopathologic and prognostic features in patients with peritoneal metastasis from mucinous adenocarcinoma, adenocarcinoma with signet ring cells, and adenocarcinoid of the appendix treated with cytoreductive surgery and perioperative intraperitoneal chemotherapy. Ann Surg Oncol. 2016;23(5):1474\u201380.","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"7007_CR7","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1055\/s-0035-1564433","volume":"28","author":"KJ Kelly","year":"2015","unstructured":"Kelly KJ. Management of appendix cancer. Clinics Colon Rectal Surg. 2015;28(4):247\u201355.","journal-title":"Clin Colon Rectal Surg"},{"issue":"12","key":"7007_CR8","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1097\/00000478-199512000-00006","volume":"19","author":"BM Ronnett","year":"1995","unstructured":"Ronnett BM, Zahn CM, Kurman RJ, Kass ME, Sugarbaker PH, Shmookler BM. Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to \u201cpseudomyxoma peritonei\u201d. Am J Surg Pathol. 1995;19(12):1390\u2013408.","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"7007_CR9","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1002\/1097-0142(20010701)92:1<85::AID-CNCR1295>3.0.CO;2-R","volume":"92","author":"BM Ronnett","year":"2001","unstructured":"Ronnett BM, Yan H, Kurman RJ, Shmookler BM, Wu L, Sugarbaker PH. Patients with pseudomyxoma peritonei associated with disseminated peritoneal adenomucinosis have a significantly more favorable prognosis than patients with peritoneal mucinous carcinomatosis. Cancer. 2001;92(1):85\u201391.","journal-title":"Cancer"},{"issue":"6","key":"7007_CR10","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1111\/his.13324","volume":"71","author":"NJ Carr","year":"2017","unstructured":"Carr NJ, Bibeau F, Bradley RF, et al. The histopathological classification, diagnosis and differential diagnosis of mucinous appendiceal neoplasms, appendiceal adenocarcinomas and pseudomyxoma peritonei. Histopathology. 2017;71(6):847\u201358.","journal-title":"Histopathology"},{"issue":"Suppl 1","key":"7007_CR11","doi-asserted-by":"publisher","first-page":"S67","DOI":"10.1038\/modpathol.2014.129","volume":"28","author":"J Misdraji","year":"2015","unstructured":"Misdraji J. Mucinous epithelial neoplasms of the appendix and pseudomyxoma peritonei. Mod Pathol. 2015;28 Suppl 1:S67\u201379.","journal-title":"Mod Pathol"},{"issue":"10","key":"7007_CR12","doi-asserted-by":"publisher","first-page":"2765","DOI":"10.1245\/s10434-009-0536-z","volume":"16","author":"TC Chua","year":"2009","unstructured":"Chua TC, Pelz JO, Kerscher A, Morris DL, Esquivel J. Critical analysis of 33 patients with peritoneal carcinomatosis secondary to colorectal and appendiceal signet ring cell carcinoma. Ann Surg Oncol. 2009;16(10):2765\u201370.","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"7007_CR13","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1097\/00000658-199502000-00002","volume":"221","author":"PH Sugarbaker","year":"1995","unstructured":"Sugarbaker PH, Jablonski KA. Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy. Ann Surg. 1995;221(2):124\u201332.","journal-title":"Ann Surg"},{"issue":"5","key":"7007_CR14","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/gm559","volume":"6","author":"H Alakus","year":"2014","unstructured":"Alakus H, Babicky ML, Ghosh P, et al. Genome-wide mutational landscape of mucinous carcinomatosis peritonei of appendiceal origin. Genome Med. 2014;6(5):43.","journal-title":"Genome Med."},{"issue":"1","key":"7007_CR15","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S1470-2045(05)70539-8","volume":"7","author":"PH Sugarbaker","year":"2006","unstructured":"Sugarbaker PH. New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome? Lancet Oncol. 2006;7(1):69\u201376.","journal-title":"Lancet Oncol."},{"issue":"1","key":"7007_CR16","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1097\/PAS.0000000000000535","volume":"40","author":"NJ Carr","year":"2016","unstructured":"Carr NJ, Cecil TD, Mohamed F, et al. A consensus for classification and pathologic reporting of pseudomyxoma peritonei and associated appendiceal neoplasia: the results of the peritoneal surface oncology group international (PSOGI) modified delphi process. Am J Surg Pathol. 2016;40(1):14\u201326.","journal-title":"Am J Surg Pathol"},{"key":"7007_CR17","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/978-1-4613-1247-5_23","volume":"82","author":"P Jacquet","year":"1996","unstructured":"Jacquet P, Sugarbaker PH. Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res. 1996;82:359\u201374.","journal-title":"Cancer Treat Res"},{"issue":"3","key":"7007_CR18","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/S1055-3207(03)00048-6","volume":"12","author":"PH Sugarbaker","year":"2003","unstructured":"Sugarbaker PH. Peritonectomy procedures. Surg Oncol Clin N Am. 2003;12(3):703\u201327, xiii.","journal-title":"Surg Oncol Clin N Am"},{"issue":"6","key":"7007_CR19","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1016\/j.hoc.2012.08.010","volume":"26","author":"S Shankar","year":"2012","unstructured":"Shankar S, Ledakis P, El Halabi H, Gushchin V, Sardi A. Neoplasms of the appendix: current treatment guidelines. Hematol Oncol Clin North Am. 2012;26(6):1261\u201390.","journal-title":"Hematol Oncol Clin North Am"},{"issue":"2","key":"7007_CR20","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","volume":"240","author":"D Dindo","year":"2004","unstructured":"Dindo D, Demartines N, Clavien P-A. Classification of surgical complications. Ann Surg. 2004;240(2):205\u201313.","journal-title":"Ann Surg"},{"issue":"2","key":"7007_CR21","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/SLA.0b013e3181b13ca2","volume":"250","author":"PA Clavien","year":"2009","unstructured":"Clavien PA, Barkun J, de Oliveira ML, et al. The Clavien\u2013Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250(2):187\u201396.","journal-title":"Ann Surg"},{"issue":"11","key":"7007_CR22","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1177\/000313481307901120","volume":"79","author":"S Shetty","year":"2013","unstructured":"Shetty S, Natarajan B, Thomas P, Govindarajan V, Sharma P, Loggie B. Proposed classification of pseudomyxoma peritonei: influence of signet ring cells on survival. Am Surg. 2013;79(11):1171\u20136.","journal-title":"Am Surg"},{"issue":"1","key":"7007_CR23","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/modpathol.3800482","volume":"19","author":"S Ogino","year":"2006","unstructured":"Ogino S, Brahmandam M, Cantor M, et al. Distinct molecular features of colorectal carcinoma with signet ring cell component and colorectal carcinoma with mucinous component. Mod Pathol. 2006;19(1):59\u201368.","journal-title":"Mod Pathol"},{"issue":"8","key":"7007_CR24","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1016\/j.humpath.2014.03.007","volume":"45","author":"SJ Sirintrapun","year":"2014","unstructured":"Sirintrapun SJ, Blackham AU, Russell G, et al. Significance of signet ring cells in high-grade mucinous adenocarcinoma of the peritoneum from appendiceal origin. Hum Pathol. 2014;45(8):1597\u2013604.","journal-title":"Hum Pathol"},{"issue":"11","key":"7007_CR25","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1038\/modpathol.2014.37","volume":"27","author":"JM Davison","year":"2014","unstructured":"Davison JM, Choudry HA, Pingpank JF, et al. Clinicopathologic and molecular analysis of disseminated appendiceal mucinous neoplasms: identification of factors predicting survival and proposed criteria for a three-tiered assessment of tumor grade. Mod Pathol. 2014;27(11):1521\u201339.","journal-title":"Mod Pathol"},{"issue":"4","key":"7007_CR26","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/sj.bjc.6604522","volume":"99","author":"AL Farquharson","year":"2008","unstructured":"Farquharson AL, Pranesh N, Witham G, et al. A phase II study evaluating the use of concurrent mitomycin C and capecitabine in patients with advanced unresectable pseudomyxoma peritonei. Br J Cancer. 2008;99(4):591\u20136.","journal-title":"Br J Cancer"},{"issue":"2","key":"7007_CR27","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1002\/cncr.24715","volume":"116","author":"JF Shapiro","year":"2010","unstructured":"Shapiro JF, Chase JL, Wolff RA, et al. Modern systemic chemotherapy in surgically unresectable neoplasms of appendiceal origin: a single-institution experience. Cancer. 2010;116(2):316\u201322.","journal-title":"Cancer"},{"issue":"3","key":"7007_CR28","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1093\/annonc\/mdr279","volume":"23","author":"CH Lieu","year":"2012","unstructured":"Lieu CH, Lambert LA, Wolff RA, et al. Systemic chemotherapy and surgical cytoreduction for poorly differentiated and signet ring cell adenocarcinomas of the appendix. Ann Oncol. 2012;23(3):652\u20138.","journal-title":"Ann Oncol"},{"issue":"2","key":"7007_CR29","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1097\/01.sla.0000133183.15705.71","volume":"240","author":"O Glehen","year":"2004","unstructured":"Glehen O, Mohamed F, Sugarbaker PH. Incomplete cytoreduction in 174 patients with peritoneal carcinomatosis from appendiceal malignancy. Ann Surg. 2004;240(2):278\u201385.","journal-title":"Ann Surg"},{"issue":"1","key":"7007_CR30","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1097\/01.sla.0000231705.40081.1a","volume":"245","author":"RM Smeenk","year":"2007","unstructured":"Smeenk RM, Verwaal VJ, Antonini N, Zoetmulder FA. Survival analysis of pseudomyxoma peritonei patients treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg. 2007;245(1):104\u20139.","journal-title":"Ann Surg"},{"issue":"2","key":"7007_CR31","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1245\/s10434-007-9691-2","volume":"15","author":"D Baratti","year":"2008","unstructured":"Baratti D, Kusamura S, Nonaka D, et al. Pseudomyxoma peritonei: clinical pathological and biological prognostic factors in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC). Ann Surg Oncol. 2008;15(2):526\u201334.","journal-title":"Ann Surg Oncol"},{"issue":"20","key":"7007_CR32","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1200\/JCO.2011.39.7166","volume":"30","author":"TC Chua","year":"2012","unstructured":"Chua TC, Moran BJ, Sugarbaker PH, et al. Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Clin Oncol. 2012;30(20):2449\u201356.","journal-title":"J Clin Oncol"},{"issue":"11","key":"7007_CR33","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1016\/j.ejso.2013.08.017","volume":"39","author":"A Sardi","year":"2013","unstructured":"Sardi A, Jimenez WA, Nieroda C, Sittig M, Macdonald R, Gushchin V. Repeated cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from appendiceal cancer: analysis of survival outcomes. Eur J Surg Oncol. 2013;39(11):1207\u201313.","journal-title":"Eur J Surg Oncol"},{"issue":"2","key":"7007_CR34","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1097\/00000658-200108000-00009","volume":"234","author":"J Esquivel","year":"2001","unstructured":"Esquivel J, Sugarbaker PH. Second-look surgery in patients with peritoneal dissemination from appendiceal malignancy: analysis of prognostic factors in 98 patients. Ann Surg. 2001;234(2):198\u2013205.","journal-title":"Ann Surg"},{"issue":"3","key":"7007_CR35","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.jamcollsurg.2012.04.023","volume":"215","author":"KI Votanopoulos","year":"2012","unstructured":"Votanopoulos KI, Ihemelandu C, Shen P, Stewart JH, Russell GB, Levine EA. Outcomes of repeat cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for the treatment of peritoneal surface malignancy. J Am Coll Surg. 2012;215(3):412\u20137.","journal-title":"J Am Coll Surg"},{"issue":"5","key":"7007_CR36","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.ejso.2013.12.021","volume":"40","author":"P Taflampas","year":"2014","unstructured":"Taflampas P, Dayal S, Chandrakumaran K, Mohamed F, Cecil TD, Moran BJ. Pre-operative tumour marker status predicts recurrence and survival after complete cytoreduction and hyperthermic intraperitoneal chemotherapy for appendiceal Pseudomyxoma Peritonei: analysis of 519 patients. Eur J Surg Oncol. 2014;40(5):515\u201320.","journal-title":"Eur J Surg Oncol"},{"issue":"8","key":"7007_CR37","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1016\/j.ejso.2015.04.005","volume":"41","author":"S Kusamura","year":"2015","unstructured":"Kusamura S, Baratti D, Hutanu I, et al. The role of baseline inflammatory-based scores and serum tumor markers to risk stratify pseudomyxoma peritonei patients treated with cytoreduction (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). Eur J Surg Oncol. 2015;41(8):1097\u2013105.","journal-title":"Eur J Surg Oncol"},{"issue":"8","key":"7007_CR38","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.1245\/s10434-007-9393-9","volume":"14","author":"D Baratti","year":"2007","unstructured":"Baratti D, Kusamura S, Martinetti A, et al. Prognostic value of circulating tumor markers in patients with pseudomyxoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2007;14(8):2300\u20138.","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"7007_CR39","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1007\/BF02574513","volume":"9","author":"S Ruth van","year":"2002","unstructured":"van Ruth S, Hart AA, Bonfrer JM, Verwaal VJ, Zoetmulder FA. Prognostic value of baseline and serial carcinoembryonic antigen and carbohydrate antigen 19.9 measurements in patients with pseudomyxoma peritonei treated with cytoreduction and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2002;9(10):961\u20137.","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"7007_CR40","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1245\/s10434-012-2627-5","volume":"20","author":"PL Wagner","year":"2013","unstructured":"Wagner PL, Austin F, Sathaiah M, et al. Significance of serum tumor marker levels in peritoneal carcinomatosis of appendiceal origin. Ann Surg Oncol. 2013;20(2):506\u201314.","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"7007_CR41","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1002\/jso.23784","volume":"111","author":"TR Oudheusden van","year":"2015","unstructured":"van Oudheusden TR, Braam HJ, Nienhuijs SW, et al. Poor outcome after cytoreductive surgery and HIPEC for colorectal peritoneal carcinomatosis with signet ring cell histology. J Surg Oncol. 2015;111(2):237\u201342.","journal-title":"J Surg Oncol"},{"issue":"18 Suppl","key":"7007_CR42","doi-asserted-by":"publisher","first-page":"LBA3503","DOI":"10.1200\/JCO.2018.36.18_suppl.LBA3503","volume":"36","author":"F Quenet van","year":"2018","unstructured":"Quenet F, Elias D, Roca L, et al. A UNICANCER phase III trial of hyperthermic intra-peritoneal chemotherapy (HIPEC) for colorectal peritoneal carcinomatosis (PC): PRODIGE 7. J Clin Oncol. 2018;36(18 Suppl):LBA3503.","journal-title":"J Clin Oncol"},{"issue":"7","key":"7007_CR43","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1002\/jso.23728","volume":"110","author":"A Prada-Villaverde","year":"2014","unstructured":"Prada-Villaverde A, Esquivel J, Lowy AM, et al. The American Society of Peritoneal Surface Malignancies evaluation of HIPEC with Mitomycin C versus Oxaliplatin in 539 patients with colon cancer undergoing a complete cytoreductive surgery. J Surg Oncol. 2014;110(7):779\u201385.","journal-title":"J Surg Oncol"},{"issue":"20","key":"7007_CR44","doi-asserted-by":"publisher","first-page":"3737","DOI":"10.1200\/JCO.2003.04.187","volume":"21","author":"VJ Verwaal","year":"2003","unstructured":"Verwaal VJ, van Ruth S, de Bree E, et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol. 2003;21(20):3737\u201343.","journal-title":"J Clin Oncol"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-018-7007-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-018-7007-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-018-7007-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T19:56:51Z","timestamp":1662580611000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-018-7007-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,6]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["7007"],"URL":"https:\/\/doi.org\/10.1245\/s10434-018-7007-3","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,6]]},"assertion":[{"value":"31 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2018","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Carlos Munoz-Zuluaga, Armando Sardi, Mary Caitlin King, Carol Nieroda, Michelle Sittig, Ryan MacDonald, and Vadim Gushchin declare that there are no conflicts of interest regarding the publication of this paper.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}